Sort
146,196 grants matching “diabetes”
NEW JERSEY HEALTHY COMMUNITIES, TOBACCO CONTROL, DIABETES PREVENTION AND CONTROL,
$748,849Lisa Holland · New Jersey State Dept/Health/Senior Srvs · U58 · FY2011 · DP
Multisystemic therapy to reduce health disparities in adolescents with asthma
$748,847Sylvie Naar-King · Wayne State University · R01 · FY2008 · HL
Improving Health Outcomes by Targeting Postpartum Patients with High Need
$748,816Elizabeth A Howell · University Of Pennsylvania · R01 · FY2025 · MD
Novel Metabolic Predictors of Diabetes in American Indians
$748,810Jinying Zhao · University Of Florida · R01 · FY2019 · DK
Research On Family Management Of Childhood Disease
$748,754Tonja Nansel · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
HIV Disease and Impairement of High Density Lipoprotein Metabolism
$748,717Michael Ilya Bukrinsky · George Washington University · R01 · FY2010 · HL
Optimizing HIV Care in Less Developed Countries
$748,704Kenneth Alan Freedberg · Massachusetts General Hospital · R01 · FY2009 · AI
DC-Baltimore Center to Improve Child Health Disparities
$748,686Renee R. Jenkins · Howard University · P20 · FY2006 · MD
P-FITS: The Pediatric Food Intake Technology System
$748,669Rick Weiss · Viocare, Inc. · R44 · FY2024 · HD
SYSTEMS-BASED DIABETES PREVENTION AND CONTROL PROGRAMS (DPCPS)
$748,667Paula F Clayton · Kansas State Dept Of Corrections · U32 · FY2007 · DP
SYSTEMS-BASED DIABETES PREVENTION AND CONTROL PROGRAMS (DPCPS)
$748,667Paula F Clayton · Kansas State Dept Of Corrections · U32 · FY2008 · DP
SYSTEMS-BASED DIABETES PREVENTION AND CONTROL PROGRAMS (DPCPS)
$748,667Paula F Clayton · Kansas State Dept Of Corrections · U32 · FY2006 · DP
Effects of GLP-l receptor agonists on cardiometabolic alterations in HIV-associated lipohypertrophy
$748,650Grace A McComsey · Case Western Reserve University · R01 · FY2023 · DK
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease
$748,638D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UG3 · FY2020 · TR
Using genetic variation to study biology of blood lipids & coronary heart disease
$748,631Gina Marie Peloso · Boston University Medical Campus · R01 · FY2022 · HL
Coronary Artery Calcification in Type 1 Diabetes
$748,596Marian J. Rewers · University Of Colorado Denver · R01 · FY2006 · HL
Metabolic, behavioral and social determinants of youth-onset T2D
$748,595Carmen R Isasi · Albert Einstein College Of Medicine · U01 · FY2024 · DK
Drug Development of GLP-1 receptor agonists
$748,585Josephine Egan · National Institute On Aging · ZIA · FY2016 · AG
Evaluating environmental control (AVOID) and inhibitory control (RESIST) strategies to improve weight management outcomes
$748,583Sarah-Jeanne Salvy · Cedars-Sinai Medical Center · R01 · FY2022 · DK
Implementing an evidence-based mHealth diet and activity intervention: Make Better Choices 2 for rural Appalachians
$748,576Nancy E Schoenberg · University Of Kentucky · R01 · FY2022 · HL
Home intervention for reducing sugary drinks & obesity in Hispanic women-infants
$748,566Michael I Goran · Children'S Hospital Of Los Angeles · R01 · FY2021 · DK
Microbiome-mediated therapies for aging and healthspan in marmosets
$748,508Corinna Nicole Ross · Texas Biomedical Research Institute · R01 · FY2022 · AG
Action For Health In Diabetes Continuation (Look AHEAD)
$748,448Karen C Johnson · University Of Tennessee Health Sci Ctr · U01 · FY2014 · DK
iPAT:Intelligent Diet Quality Pattern Analysis for Harmonized MA-National Trials
$748,446Hua Fang · University Of Massachusetts Dartmouth · R01 · FY2021 · DK
Circulating Biomarker Consortium for Pancreatic Cancer Early Detection
$748,441Brian Matthew Wolpin · Dana-Farber Cancer Inst · U01 · FY2021 · CA